文献速递关节外科创伤骨科

丙型肝炎感染与全肩关节置换术后并发症风险升高相关吗?

Is Hepatitis C Infection Associated With a Higher Risk of Complications After Total Shoulder Arthroplasty?
PubMed 文献 · Clin Orthop Relat Res · 2016-07-22

基于PearlDiver数据库2005至2012年记录,纳入1466例合并丙型肝炎的全肩关节置换患者与21502例匹配对照。丙型肝炎组感染、脱位、骨折、翻修、全身并发症及输血 odds 均升高,但机制可能不单与病毒相关,或与病例复杂度和术后社会经济因素有关。

要点

  • 丙型肝炎患者全肩关节置换术后3个月、6个月、1年感染 odds 均升高。
  • 丙型肝炎患者1年内脱位、骨折及2年内翻修全肩关节置换 odds 升高。
  • 丙型肝炎患者3个月内全身并发症及输血 odds 升高。

核心结论

  • 丙型肝炎与全肩关节置换术后感染、脱位、骨折、翻修、全身并发症及输血风险升高相关。
  • 作者认为并发症机制可能不单与病毒相关,更可能与病例复杂度及其他术后社会经济因素有关。

研究设计与样本

  • 利用PearlDiver数据库2005至2012年记录,按ICD-9手术码识别全肩关节置换(解剖或反式)患者。
  • 丙型肝炎组1466例,按年龄、性别、肥胖及糖尿病匹配非丙型肝炎对照组21502例,排除乙型肝炎合并感染或HIV患者。
  • 证据等级为III级,治疗性研究。

主要发现

  • 感染3个月OR 1.7(95%CI 1.1-2.6,p=0.015)、6个月OR 1.7(95%CI 1.3-2.4,p=0.001)、1年OR 2.1(95%CI 1.7-2.7,p<0.001)。
  • 翻修全肩关节置换1年OR 1.5(95%CI 1.1-2.9,p=0.008)、2年OR 1.6(95%CI 1.2-2.0,p=0.001)。
  • 脱位1年OR 1.6(95%CI 1.2-2.2,p<0.001),术后骨折1年OR 1.8(95%CI 1.2-2.6,p=0.002)。
  • 全身或内科并发症3个月OR 1.3(95%CI 1.0-1.6,p=0.022),输血3个月OR 1.7(95%CI 1.4-1.9,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite recent advances in the treatment of hepatitis C, it is estimated that nearly 4 million Americans have a chronic form of the disease. Although research in lower-extremity arthroplasty suggests patients with hepatitis C are at risk for increased complications, including postoperative bleeding, acute postoperative infection, and general medical complications, no similar studies have investigated this question in patients undergoing total shoulder arthroplasty (TSA). QUESTIONS/PURPOSES: We asked whether there is an increased risk of postoperative complications after TSA among patients who have hepatitis C, and if so, what complications in particular seem more likely to occur in this population? METHODS: Patients who underwent TSA, including anatomic or reverse TSA, were identified in the PearlDiver database using ICD-9 procedure codes. This is a for-fee insurance patient-records database that contains more than 100 million individual patient records from 2005 to 2012. The Medicare data in the database are the complete 100% Medicare Standard Analytical File indexed to allow for patient tracking with time. Patients with hepatitis C who underwent shoulder arthroplasty then were identified using ICD-9 codes. Patients with hepatitis B coinfection or HIV were excluded. A control cohort of patients without hepatitis C who underwent TSA was created and matched to the study cohort based on age, sex, obesity, and diabetes mellitus. A total of 1466 patients with hepatitis C and 21,502 control patients were included. The two cohorts were statistically similar in terms of sex (53% females in study and control groups), age (nearly ½ of each cohort younger than 65 years), obesity (approximately 17% of each cohort were obese), diabetes (approximately 40% of each cohort had diabetes), and followup of each cohort occurred throughout the length of the database from 2005 to 2012. Postoperative complications were assessed using ICD-9 and Current Procedural Terminology codes and compared between cohorts. RESULTS: Patients with hepatitis C, when compared with matched control subjects, had greater odds of infection within 3 months (odds ratio [OR], 1.7; 95% CI, 1.1-2.6; p = 0.015), 6 months (OR, 1.7; CI, 1.3-2.4; p = 0.001), and 1 year (OR, 2.1; CI, 1.7-2.7; p < 0.001); revision TSA within 1 year (OR, 1.5; CI, 1.1-2.9; p = 0.008) and 2 years (OR, 1.6; CI, 1.2-2.0; p = 0.001), dislocation within 1 year (OR, 1.6; CI, 1.2-2.2; p < 0.001); postoperative fracture within 1 year (OR, 1.8; CI, 1.2-2.6; p = 0.002); systemic or medical complications within 3 months (OR, 1.3; CI, 1.0-1.6; p = 0.022); and blood transfusion within 3 months (OR, 1.7; CI, 1.4-1.9; p < 0.001). CONCLUSIONS: Hepatitis C is associated with an increased risk for complications after TSA, including infection, dislocation, fracture, revision TSA, systemic complications, and blood transfusion compared with matched control subjects. Although this study is able to identify increased odds of complications in patients with hepatitis C, the mechanism by which these occur is likely not solely related to the virus, and is more likely related to a higher degree of case complexity in addition to other postoperative socioeconomic factors. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Cancienne JM, Dempsey IJ, Holzgrefe RE, et al. Is Hepatitis C Infection Associated With a Higher Risk of Complications After Total Shoulder Arthroplasty? Clin Orthop Relat Res. 2016. PMID: 27448222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。